Genome editing technique is utilized for the changes that are to be done in the DNA of a cell or an organism. The technique involves cutting DNA sequences for the addition or removing the DNA in the genome. The changes in the genome are done for the required characteristics of the cell. Genome editing is done for the research purpose, the treatment of the diseases, and the biotechnological purpose. The global genome editing market growth is attributable to the rise in prevalence of cancer & other genetic disorders and continuous technological advancements in gene-editing tools are factors driving the market growth. Furthermore, technological advancements in healthcare IT allow the use of artificial intelligence (AI) for manufacturing CRISPR Systems which are expected to foster genome editing and enhance the genome editing market growth in the coming years. For instance, In March 2019, Oxford Biomedica plc collaborated with Microsoft Research for R&D of cloud and machine learning to improve the production and quality of next-generation gene therapy vectors such as LentiVector. Under this collaboration, Oxford Biomedica has utilized Microsoft’s Azure intelligent cloud platform to develop in silico models and innovative algorithms to advance the next-generation cell and gene delivery technology.